LC-MS/TOF Characterization and Stability Study of Artesunate in Different Solvent Systems

Artemisinin (ART) is a sesquiterpene lactone and a popular malaria drug used in many parts of the world. Artesunate (ARTS) is a semi-synthetic derivative of ART with improved pharmacokinetic properties. However, the half-life of ARTS is less than an hour in vivo. The analysis of this drug in vitro i...

Full description

Bibliographic Details
Published in:	Separations
Main Authors:	Kogila Oke, Amos Mugweru
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Subjects:	artemisinin dihydroartemisinin artesunate HPLC/TOF-MS
Online Access:	https://www.mdpi.com/2297-8739/9/8/218

Similar Items

Artemisinin and Its Derivatives as Potential Anticancer Agents
by: Luan Wen, et al.
Published: (2024-08-01)

Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01)

Artemisinin DNA Base Interaction Studies in Presence of Fe(II): LC/TOF MS Separation of Reaction Products
by: Kogila Oke, et al.
Published: (2021-09-01)

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
by: Qi Jin, et al.
Published: (2023-02-01)

Artemisinin and Its Derivatives: Promising Therapeutic Agents for Age-Related Macular Degeneration
by: Chun Liu, et al.
Published: (2025-04-01)

Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates
by: Elena Marchesi, et al.
Published: (2023-08-01)

New Uses for Old Drugs: The Tale of Artemisinin Derivatives in the Elimination of Schistosomiasis Japonica in China
by: Yi-Xin Liu, et al.
Published: (2014-09-01)

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
by: Abel Nhama, et al.
Published: (2025-07-01)

Bioequivalence of Two Intravenous Artesunate Products with Its Active Metabolite Following Single and Multiple Injections
by: Qigui Li, et al.
Published: (2011-01-01)

Severe Embryotoxicity of Artemisinin Derivatives in Experimental Animals, but Possibly Safe in Pregnant Women
by: Qigui Li, et al.
Published: (2009-12-01)

Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment
by: Anthony McDowell, et al.
Published: (2021-02-01)

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
by: Sanjeev Krishna, et al.
Published: (2015-01-01)

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials
by: Alphonse Ouédraogo, et al.
Published: (2024-12-01)

Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to <i>Artemisia</i> sp., Artemisinin, and Its Derivatives
by: Pamela Weathers, et al.
Published: (2024-05-01)

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
by: Celine I. Mandara, et al.
Published: (2019-03-01)

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam
by: Thanh Nguyen, et al.
Published: (2012-06-01)

Editorial: Drugs and methods that enhance the anti-cancer efficacy of artesunate
by: Tuğçenur Uzun
Published: (2025-03-01)

From malaria fighter to diabetes guardian: the emerging role of artesunate in treating diabetes and diabetic complications
by: Dongze Li, et al.
Published: (2025-05-01)

Identification and pharmacokinetics of saponins in Rhizoma Anemarrhenae after oral administration to rats by HPLC-Q-TOF/MS and HPLC-MS/MS
by: Wang Hai-Qiao, et al.
Published: (2021-12-01)

Effect of processing on the alkaloids in Aconitum tubers by HPLC-TOF/MS
by: Min Liu, et al.
Published: (2017-06-01)

Chemical Profiles and Simultaneous Quantification of Aurantii fructus by Use of HPLC-Q-TOF-MS Combined with GC-MS and HPLC Methods
by: Yingjie He, et al.
Published: (2018-08-01)

Modulation of the Antimelanoma Activity Imparted to Artemisinin Hybrids by the Monoterpene Counterpart
by: Elisa De Marchi, et al.
Published: (2024-07-01)

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
by: Nguyen Van Hong, et al.
Published: (2015-07-01)

Quality control of injectable artesunate marketed in Kisangani in the Democratic Republic of the Congo
by: Emile TWENI BARUTI, et al.
Published: (2025-08-01)

Post-artesunate delayed haemolysis ‒ report of four cases and review of the literature
by: Olivier Boillat, et al.
Published: (2015-11-01)

Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
by: Richard M. Hoglund, et al.
Published: (2018-09-01)

Influence of Temperature, Solvent and pH on the Selective Extraction of Phenolic Compounds from Tiger Nuts by-Products: Triple-TOF-LC-MS-MS Characterization
by: Elena Roselló-Soto, et al.
Published: (2019-02-01)

IDENTIFICATION AND QUANTIFICATION OF SOME PESTICIDE METABOLITES FROM VEGETABLES BY GC-TOF-MS AND LC-MS-QQQ
by: Adela MEGHESAN-BREJA, et al.
Published: (2017-09-01)

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
by: Pascal Ringwald, et al.
Published: (2015-07-01)

K13-propeller gene polymorphisms of Plasmodium falciparum and the therapeutic effect of artesunate among migrant workers returning to Guangxi, China (2014–2017)
by: Jun Li, et al.
Published: (2019-10-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance
by: Mahamat Souleymane Issa, et al.
Published: (2023-08-01)

Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC–MS/MS peptidome analysis
by: Vasin Thanasukarn, et al.
Published: (2025-01-01)

Longitudinal study of Plasmodium pathogens identifies new loci associated with artemisinin resistance
by: Elizabeth A. Winzeler
Published: (2017-04-01)

Application of GC–TOF/MS and GC×GC–TOF/MS to Discriminate Coffee Products in Three States (Bean, Powder, and Brew)
by: Xiaolei Fang, et al.
Published: (2023-08-01)

Efficacy and safety of artemisinin-naphthoquine <it>versus</it> dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
by: Tjitra Emiliana, et al.
Published: (2012-06-01)

Comparative, observational study of the use of artesunate injections along with standard-of-care treatment versus only standard-of-care treatment in moderate and severe acute respiratory distress syndrome cases of COVID-19-positive infections
by: Babita A Ghodke, et al.
Published: (2022-01-01)

Development of an LC–TOF/MS Method to Quantify Camrelizumab in Human Serum
by: Li Song, et al.
Published: (2024-10-01)

A REVIEW OF CLINICAL STUDIES OF ANTICANCER ACTIVITY OF ARTEMISININ DERIVATIVE
by: D. A. Konovalov, et al.
Published: (2018-11-01)

Severe Delayed Hemolysis Associated with Regulated Parenteral Antimalarial Drug
by: Julia Lee, et al.
Published: (2015-01-01)

Artemisinins induce endoplasmic reticulum stress in acute leukaemia cells in vitro and in vivo
by: Rubia Isler Mancuso, et al.
Published: (2021-11-01)